Businesses race to gain competitive advantage on-line
This article was originally published in Clinica
Executive Summary
Business-to-business e-commerce in the US healthcare sector will rise dramatically from $6 billion in 1999 to an estimated $348 billion by 2004, according to Forrester Research, a market research company that analyses the impact of technology change. And this may even underestimate the size of the market - a report prepared by US bancorp Piper Jaffray values healthcare e-commerce at more than three times the Forrester forecast - $1 trillion by 2003.
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.